日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD44/POU2F2/BCL9L axis mediates MIF-driven SPP1(+)TAM activation in colorectal cancer metastasis

CD44/POU2F2/BCL9L轴介导MIF驱动的SPP1(+)TAM活化在结直肠癌转移中的作用

Zhang, Fan; Zhao, Bingquan; Fan, Xueying; Shi, Zhiqiang; Guo, Peilan; Zhang, Haibo; Kwan, Hiu-Yee; Liu, Zhongqiu; Su, Tao

Genomic diversity and BCL9L mutational status in circulating tumor cells predict overall survival in metastatic colorectal cancer

循环肿瘤细胞中的基因组多样性和BCL9L突变状态可预测转移性结直肠癌患者的总生存期

Alves, Joao M; Estévez-Gómez, Nuria; Piñeiro, Roberto; Muinelo-Romay, Laura; Mondelo-Macía, Patricia; Salgado, Mercedes; Iglesias-Gómez, Agueda; Codesido-Prada, Laura; Diez-Martín, Astrid; Cubiella, Joaquin; Posada, David

Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration

靶向 BCL9/BCL9L 可通过促进常规 1 型树突状细胞 (cDC1) 活化和肿瘤浸润来增强抗原呈递。

Fenglian He # ,Zhongen Wu # ,Chenglong Liu # ,Yuanyuan Zhu # ,Yan Zhou ,Enming Tian ,Rina Rosin-Arbesfeld ,Dehua Yang ,Ming-Wei Wang ,Di Zhu

Corrigendum: miR-766-3p targeting BCL9L suppressed tumorigenesis, epithelial-mesenchymal transition, and metastasis through the β-catenin signaling pathway in osteosarcoma cells

更正:miR-766-3p靶向BCL9L,通过β-catenin信号通路抑制骨肉瘤细胞的肿瘤发生、上皮-间质转化和转移。

Zhang, Sheng; Chen, Hongtao; Liu, Wanshun; Fang, Le; Qian, Zhanyang; Kong, Renyi; Zhang, Qi; Li, Juming; Cao, Xiaojian

The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis

Bcl9/Bcl9L与β-catenin和Pygopus的相互作用促进乳腺癌的生长、侵袭和转移。

Vida Vafaizadeh ,David Buechel ,Natalia Rubinstein ,Ravi K R Kalathur ,Lorenzo Bazzani ,Meera Saxena ,Tomas Valenta ,George Hausmann ,Claudio Cantù ,Konrad Basler ,Gerhard Christofori

BCL9/BCL9L in hepatocellular carcinoma: will it or Wnt it be the next therapeutic target?

BCL9/BCL9L在肝细胞癌中的作用:它会是下一个治疗靶点,还是Wnt会?

Moghe, Akshata; Monga, Satdarshan P

miR-766-3p Targeting BCL9L Suppressed Tumorigenesis, Epithelial-Mesenchymal Transition, and Metastasis Through the β-Catenin Signaling Pathway in Osteosarcoma Cells

miR-766-3p通过β-catenin信号通路靶向BCL9L抑制骨肉瘤细胞的肿瘤发生、上皮-间质转化和转移

Zhang, Sheng; Chen, Hongtao; Liu, Wanshun; Fang, Le; Qian, Zhanyang; Kong, Renyi; Zhang, Qi; Li, Juming; Cao, Xiaojian

KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling

KDM3通过Wnt/β-catenin信号通路表观遗传调控人类结直肠癌干细胞的致瘤潜能

Jiong Li ,Bo Yu ,Peng Deng ,Yingduan Cheng ,Yongxin Yu ,Kareena Kevork ,Sivakumar Ramadoss ,Xiangming Ding ,Xinmin Li ,Cun-Yu Wang

BCL9L expression in pancreatic neoplasia with a focus on SPN: a possible explanation for the enigma of the benign neoplasia

BCL9L在胰腺肿瘤(尤其是SPN)中的表达:良性肿瘤之谜的一种可能解释

Hallas, Cora; Phillipp, Julia; Domanowsky, Lukas; Kah, Bettina; Tiemann, Katharina